Transgene Reports Results From Clinical Study of TG4001 in Combination With Avelumab in Advanced HPV-Positive Cancers
Go back to Transgene Reports Results From Clinical Study of TG4001 in Combination With Avelumab in Advanced HPV-Positive Cancers| Pfizer Inc. (NYSE: PFE) | Delayed: 27.64 +0.18 (0.66%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.46 | 52 Week High | $37.39 | |||
| Open | $27.62 | 52 Week Low | $28.25 | |||
| Day High | $27.81 | P/E | 16.75 | |||
| Day Low | $27.55 | EPS | $1.65 | |||
| Volume | 28,439,187 | |||||
| Puritan Financial Group, Inc. (AMEX: TNG) | Delayed: 0.01 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.01 | 52 Week High | $0.01 | |||
| Open | $0.01 | 52 Week Low | $0.01 | |||
| Day High | $0.01 | P/E | N/A | |||
| Day Low | $0.01 | EPS | $0.00 | |||
| Volume | 0 | |||||
